Newsletter | June 21, 2022

06.21.22 -- Preparing To Commercially Scale Cell Therapies

 
Are Real-Time Gene Therapy Test Results Possible?
 

Along with the complexities of vaccine and viral-based gene therapy process development comes the need for analytical techniques that can help assess quality parameters, especially in real time.

Radiance Label-Free Monitoring Of AAV Transfection In HEK293 Cells
 

Improve the characterization of cell-based AAV transfection and production, increase the efficiency and accuracy of both processes, and shorten development time.

Overcoming Commercialization Challenges For Cell And Gene Therapies
 

This panel discussion highlights technical and regulatory hurdles associated with development and manufacturing steps and strategies and solutions to facilitate development through commercialization.

Is Your Partner Prepared For Commercial-Scale Cell Therapies?
 

In this review, we discuss a few attributes that should be considered when planning manufacturing at scale for your cell therapy.